Omnicell to Exhibit at Dubai International Pharmaceuticals and Technologies Conference and Exhibition

DUBAI, United Arab Emirates, March 11, 2012 /PRNewswire/ --

- Omnicell will Demonstrate Recently Introduced G4 Medication Automation Platform

Omnicell, Inc., (NASDAQ:OMCL) a leading global provider of medication and supply management solutions and analytics software for healthcare facilities, will exhibit its state-of-the-art G4 technology at the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT) March 12-14 at the Dubai International Convention & Exhibition Centre. DUPHAT is one of the most recognized and significant pharmaceutical events in the Middle East and North Africa.

"Our vision to meet the automated medication and supply delivery needs of healthcare customers in the Middle East was advanced with the opening of our regional office and training center in Dubai in May 2011," said Gary Ervin, Omnicell vice president of international operations. "Our Dubai Center was the first of its kind to be established by a leading U.S. medication and supply automation company. We are committed to delivering Omnicell's award winning technology and training throughout the Middle East, customized to suit local healthcare requirements."

During the DUPHAT exhibition, attendees will have the opportunity to meet Omnicell experts to discuss medication automation best practices and to see Omnicell's recently introduced G4 medication automation platform in demonstration. The G4 platform features a single unified medication database, the Savvy Mobile Medication System and the newly designed Anesthesia Workstation. Also highlighted will be the new integrated Medication Label Printer, a unique Omnicell solution that supports accurate medication administration with patient-specific labels that are efficiently printed at the mediation cabinet.

Omnicell automation solutions are recognized with top honors by the leading independent rating agency, KLAS, based on extensive interviews of U.S. healthcare executives. For example, Omnicell has achieved the top KLAS distinction six years in a row for the OmniRx® automated medication system as well as "Best in KLAS" distinctions for its Pharmacy Automation Medication Carousels and the KLAS Category Leader award for its Anesthesia Workstation. In customer surveys, Omnicell has been consistently recognized for its innovation and long-term customer satisfaction.

Visit Omnicell's DUPHAT 2012 display in booth 616/617.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of automated and business information solutions enabling hospitals and healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. Through seamless integration with a hospital's existing IT infrastructure, Omnicell solutions empower healthcare facilities to achieve comprehensive automation of medication and supply management from the arrival at the loading dock to the patient's bedside. Omnicell also provides healthcare facilities with business analytics software designed to improve medication diversion detection and regulatory compliance.

Since 1992, Omnicell's customer base has grown to over 2,500 hospital customers worldwide. Omnicell's solutions address changing healthcare regulations while providing effective control of costs, charge capture for payer reimbursement and inventory management of medications and supplies.

For more information about Omnicell, please visit http://www.omnicell.com

OMCL-G